Internal email proposes US should reassess support for UK claim to islands because of lack of support for Iran war UK politics live – latest updates The UK’s position on the Falklands is resolute and unchanging, Downing Street has insisted, after a leaked Pentagon internal email proposed the US should reassess its support for Britain’s claim to the islands because of a lack of support over Iran. K...
Internal email proposes US should reassess support for UK claim to islands because of lack of support for Iran war UK politics live – latest updates The UK’s position on the Falklands is resolute and unchanging, Downing Street has insisted, after a leaked Pentagon internal email proposed the US should reassess its support for Britain’s claim to the islands because of a lack of support over Iran. Keir Starmer’s spokesperson did not push back against the likely veracity of the email but insisted that the UK’s defence and security relationship with the US remained extremely strong. Continue reading...
narvo vexar Merck's ( MRK ) $6.7B deal to acquire Terns Pharmaceuticals ( TERN ), announced in March, has made it through the expiration of the Hart-Scott-Rodino Act, signaling there are no antitrust concerns with the transaction from regulators. The deal is a cash tender with Merck purchasing all outstanding shares of common stock of Terns for $53.00 each. Closing is expected in Q2. More on Merck...
narvo vexar Merck's ( MRK ) $6.7B deal to acquire Terns Pharmaceuticals ( TERN ), announced in March, has made it through the expiration of the Hart-Scott-Rodino Act, signaling there are no antitrust concerns with the transaction from regulators. The deal is a cash tender with Merck purchasing all outstanding shares of common stock of Terns for $53.00 each. Closing is expected in Q2. More on Merck Merck: Aggressive M&A Efforts To Prepare For A Keytruda Patent Cliff Merck's Deal For Terns And Its Stellar CML Drug Candidate Looks Like Good Business Merck & Co., Inc. (MRK) M&A Call Transcript Merck inks AI deal worth up to $1B with Google Cloud Inhibrx cancer drug reportedly drawing interest of Merck and rivals
TSMC shares hover around a record high on Taiwan policy easing and booming AI demand, with strong earnings, upbeat guidance and rising analyst estimates.
TSMC shares hover around a record high on Taiwan policy easing and booming AI demand, with strong earnings, upbeat guidance and rising analyst estimates.
Jeff Schear/Getty Images Entertainment Johnson & Johnson ( JNJ ) on Friday announced that it has agreed to acquire privately owned MedTech Atraverse Medical in a bid to expand its cardiac ablation portfolio with the San Diego-based startup’s left-heart access system. Atraverse Medical’s HOTWIRE Transseptal Access System, cleared by the FDA in December as a radiofrequency-based system designed to a...
Jeff Schear/Getty Images Entertainment Johnson & Johnson ( JNJ ) on Friday announced that it has agreed to acquire privately owned MedTech Atraverse Medical in a bid to expand its cardiac ablation portfolio with the San Diego-based startup’s left-heart access system. Atraverse Medical’s HOTWIRE Transseptal Access System, cleared by the FDA in December as a radiofrequency-based system designed to access the left atrium, has already been used to perform roughly 3,000 medical procedures, J&J ( JNJ ) said. “Achieving safe and precise access to the left atrium remains one of the most critical steps in atrial fibrillation ablation,” the company added. According to JNJ, the proposed acquisition, expected to close in Q2 2026, will strengthen its portfolio of cardiac ablation solutions, which helped its cardiovascular franchise achieve $8.9B in sales in 2025 with ~16% YoY growth. Financial terms of the deal were not disclosed. More on Johnson & Johnson Johnson & Johnson: Why I See Downside Ahead Johnson & Johnson (JNJ) Q1 2026 Earnings Call Transcript Johnson & Johnson Q1 Earnings Review: Why You Should Be Buying The Stock Today JNJ snaps six straight sessions of losses J&J's Imaavy demonstrates long-term disease control in myasthenia gravis
The Trump administration and congressional Republicans have spent the last year trying to defang the Endangered Species Act , the country’s bedrock conservation law. But one of the most aggressive and far-reaching attempts just faced a major setback—and concerns from within the party were at least part of the reason. Republicans in the US House of Representatives abruptly canceled a vote that had ...
The Trump administration and congressional Republicans have spent the last year trying to defang the Endangered Species Act , the country’s bedrock conservation law. But one of the most aggressive and far-reaching attempts just faced a major setback—and concerns from within the party were at least part of the reason. Republicans in the US House of Representatives abruptly canceled a vote that had been scheduled for Wednesday—Earth Day—on legislation that aims to codify into law many of President Donald Trump’s moves to weaken endangered species protections. Some lawmakers, mostly in tourism-dependent areas along the Gulf of Mexico, expressed concerns about the bill. “Don’t tread on my turtles. Protected means protected,” US Rep. Anna Paulina Luna (R-Fla.) wrote in a social media post on Monday ahead of the then-pending vote. Read full article Comments
My top 10 things to watch Friday, April 24 1. Stocks are headed for a higher open. Oil prices and bond yields are down. A report from Reuters fueled hopes that peace talks between the United States and Iran would take place soon. President Donald Trump said yesterday that Israel and Lebanon agreed to extend their ceasefire. Tech stocks are soaring on last night's incredible earnings report from In...
My top 10 things to watch Friday, April 24 1. Stocks are headed for a higher open. Oil prices and bond yields are down. A report from Reuters fueled hopes that peace talks between the United States and Iran would take place soon. President Donald Trump said yesterday that Israel and Lebanon agreed to extend their ceasefire. Tech stocks are soaring on last night's incredible earnings report from Intel. 2. Intel shares are rocketing 25% higher this morning. The once down-and-out chipmaker continues to fire on all cylinders under Lip Bu Tan, who has only been CEO for 13 months. Intel did next year's number now. As I posted on X this morning, Intel stock can still be bought here; so can Advanced Micro Devices and our newest position, Arm , which has been a freight train this year. 3. Arm is benefiting from Meta Platforms ' latest compute agreement. The Facebook and Instagram company cut a multiyear deal for thousands of Graviton chips from Amazon Web Services. Yep, you guessed it: Gravitons are Arm-based central processing units. CPUs are all the rage lately to manage agentic AI. Meta and Amazon are also Club names. 4. Procter & Gamble reported better-than-expected quarterly earnings and revenue. Volume grew for the first time in a year. On organic growth, beauty was the star with a big beat. Grooming missed. The Club stock jumped more than 3% on the print. 5. Barclays cut its Honeywell price target to $243 from $255 following yesterday's earnings. Analysts said that the aerospace unit "has some work to do to win over the investment community." Boy, do people dislike this company. We saw the quarter as disappointing but a sign that the industrial conglomerate will deliver on its breakup plans. 6. Dover 's PT was taken up to $230 from $206 over at Barclays. Analysts pointed to the company's strong first-quarter results yesterday and described 2026 earnings guidance as "quite conservative." Ahead of the release, I was on the fence about whether it made sense to still own ...
Csquare filed confidentially for a US initial public offering, a signal that more data center companies are lining up to sell shares for the first time over the coming year. The Dallas-based provider of colocation and data center services announced on Friday that it had submitted a draft registration statement on Form S-1 to the US Securities and Exchange Commission. The number of shares to be reg...
Csquare filed confidentially for a US initial public offering, a signal that more data center companies are lining up to sell shares for the first time over the coming year. The Dallas-based provider of colocation and data center services announced on Friday that it had submitted a draft registration statement on Form S-1 to the US Securities and Exchange Commission. The number of shares to be registered as well as the price range have not yet been determined, the company said. The Brookfield Infrastructure Partners- backed company joins a rush of new listings as the companies building out the backbone to support artificial intelligence’s energy needs seek to raise funds. Amazon-backed X-Energy Inc. , which uses nuclear reactors to power AI, raised roughly $1 billion this week while Blackstone Inc. plans to raise about $2 billion for its new data-center acquisition vehicle. Csquare itself manages 80 data centers across 30 markets including New York, Los Angeles and London, according to its website . The company, formerly known as Centersquare, announced that it acquired ten data centers with an enterprise value of $1 billion in October. Companies typically pursue confidential IPO filings to maintain greater control over the process and limit reputation risk. This approach allows them to engage with regulators and respond to SEC feedback without public scrutiny. Publicly announcing a confidential filing, on the other hand, can serve strategic purposes such as building market momentum and gauging investor interest.
manassanant pamai/iStock via Getty Images Japan's equity markets edged higher on Friday despite fresh inflation data that underscored the delicate balancing act facing the Bank of Japan. The Nikkei 225 rose 0.6% toward 59,500 while the broader Topix gained 0.4% to 3,730, even as the Japanese yen weakened toward 160 per U.S. dollar, on track for a nearly 1% weekly decline, raising concerns about im...
manassanant pamai/iStock via Getty Images Japan's equity markets edged higher on Friday despite fresh inflation data that underscored the delicate balancing act facing the Bank of Japan. The Nikkei 225 rose 0.6% toward 59,500 while the broader Topix gained 0.4% to 3,730, even as the Japanese yen weakened toward 160 per U.S. dollar, on track for a nearly 1% weekly decline, raising concerns about import-driven price pressures down the line. March CPI data released Friday showed annual inflation rising to 1.5%, up from 1.3% in February, with the monthly CPI jumping 0.4% to its highest level since January 2025. Against this macro backdrop of modest but building inflationary pressure and a weakening yen, the following list ranks the top 10 U.S.-listed Japanese ADRs by their year-to-date performance, offering a snapshot of which Japanese companies have held up best for international investors through the first four months of 2026. SoftBank Corp. ( SOBKY ) leads the list with a YTD gain of 0.15%, followed by Coca-Cola Bottlers Japan Holdings ( CCOJY ) at 0.39% and SECOM ( SOMLY ) at 0.79%, a tight cluster at the top that reflects the broadly muted returns Japanese equities have delivered in U.S. dollar terms as yen weakness erodes offshore gains. Fanuc Corporation ( FANUY ) and Japan Tobacco ( JAPAY ) round out the top five with gains of 1.13% and 1.23%, the only two names on the list carrying Quant Ratings, both Holds. KOSE Holdings ( KSRYY ) posts the strongest absolute YTD return on the list at 2.81%, reflecting resilience in Japan's premium beauty and cosmetics segment, while Sanrio ( SNROY ) and Obayashi ( OBYCF ) follow closely. Here is the list: SoftBank Corp. ( SOBKY ), YTD performance: 0.15% Coca-Cola Bottlers Japan Holdings Inc. ( CCOJY ), YTD performance: 0.39% SECOM CO., LTD. ( SOMLY ), YTD performance: 0.79% Fanuc Corporation ( FANUY ), YTD performance: 1.13% Japan Tobacco Inc. ( JAPAY ), YTD performance: 1.23% Digital Garage, Inc. ( DLGEF ), YTD performance: ...